SCHEMBL20587282

SCHEMBL20587282

Cc1ccc(O)c(C=NNC(=O)c2cc(Br)cc(Br)c2)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 4/20 0.66
KDM4E B2RXH2 6/20 0.61
RAB9A P51151 5/20 0.61
MAPT P10636 5/20 0.61
NPC1 O15118 3/20 0.61
HTT P42858 3/20 0.61
LMNA P02545 2/20 0.61
ALPL P05186 1/20 0.61
GLA P06280 1/20 0.61
ALPI P09923 1/20 0.61
ALPG P10696 1/20 0.61
KMT2A Q03164 6/20 0.59
MEN1 O00255 3/20 0.59
KLF5 Q13887 2/20 0.59
ASF1A Q9Y294 2/20 0.58
MITF O75030 2/20 0.58
POLB P06746 2/20 0.58
PSMD14 O00487 1/20 0.58
MMP2 P08253 1/20 0.58
BLM P54132 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22179644 1.00 PIK3CG (0.66) PIK3CGKDM4ERAB9AMAPTNPC1
SCHEMBL20587281 1.00 PIK3CG (0.66) PIK3CGKDM4ERAB9AMAPTNPC1
SCHEMBL26974386 0.90 PIK3CG (0.60) PIK3CGKDM4ERAB9AMAPTNPC1
SCHEMBL26974369 0.90 RAB9A (0.73) PIK3CGKDM4ERAB9AMAPTNPC1
SCHEMBL26974374 0.89 PIK3CG (0.65) PIK3CGKDM4ERAB9AMAPTNPC1
SCHEMBL20587552 0.88 KMT2A (0.74) PIK3CGKDM4ERAB9AMAPTNPC1
SCHEMBL22179550 0.88 KMT2A (0.74) PIK3CGKDM4ERAB9AMAPTNPC1
SCHEMBL20587553 0.88 KMT2A (0.74) PIK3CGKDM4ERAB9AMAPTNPC1
SCHEMBL685060 0.86 MAPT (0.72) PIK3CGKDM4ERAB9AMAPTNPC1
SCHEMBL22179639 0.85 RAB9A (0.61) PIK3CGKDM4ERAB9AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12325678-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2025-06-10 US disclosed
US-20240124392-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2024-04-18 US disclosed
US-11858880-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2024-01-02 US disclosed
US-20220394973-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-12-15 US disclosed
US-11414378-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-08-16 US disclosed
US-20200207705-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2020-07-02 US disclosed
EP-3638649-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS The Research Foundation for The State University of New York (US) 2020-04-22 EP disclosed
WO-2018232298-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2018-12-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220394973-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS ERG28, UGCG, DPM1 PIK3CG 488/4885KDM4E 1377/4885RAB9A 1994/4885
US-12325678-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids ERG28, UGCG, SMPD1 PIK3CG 383/4885KDM4E 1113/4885RAB9A 2101/4885
US-20200207705-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS ERG28, UGCG, DPM1 PIK3CG 488/4885KDM4E 1377/4885RAB9A 1994/4885
US-11858880-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids ERG28, UGCG, DPM1 PIK3CG 488/4885KDM4E 1377/4885RAB9A 1994/4885
US-20240124392-A1 ANTI-FUNGALS COMPOUNDS TARGETING THE SYNTHESIS OF FUNGAL SPHINGOLIPIDS ERG28, UGCG, DPM1 PIK3CG 488/4885KDM4E 1377/4885RAB9A 1994/4885
US-11414378-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids ERG28, UGCG, LSS PIK3CG 378/4885KDM4E 1060/4885RAB9A 2178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.